John P. Mogensen

487 total citations
17 papers, 405 citations indexed

About

John P. Mogensen is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, John P. Mogensen has authored 17 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Physiology and 4 papers in Organic Chemistry. Recurrent topics in John P. Mogensen's work include Peroxisome Proliferator-Activated Receptors (10 papers), Adenosine and Purinergic Signaling (5 papers) and Receptor Mechanisms and Signaling (4 papers). John P. Mogensen is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (10 papers), Adenosine and Purinergic Signaling (5 papers) and Receptor Mechanisms and Signaling (4 papers). John P. Mogensen collaborates with scholars based in Denmark, United Kingdom and Belgium. John P. Mogensen's co-authors include Per Sauerberg, Jan Fleckner, Erik Max Wulff, Lone Jeppesen, Ingrid Pettersson, Lars Ynddal, Klaus Stensgaard Frederiksen, L. Anders Svensson, Paul S. Bury and Zdeněk Polívka and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Medicinal Chemistry and Journal of Lipid Research.

In The Last Decade

John P. Mogensen

17 papers receiving 396 citations

Peers

John P. Mogensen

PHYSI

PHARM

BIOCH

Lars Ynddal Denmark

Justin Ansell United States

Daniel Boring United States

A W Bull United States

Soumya Sasi United States

Erik Max Wulff Denmark

Rachid Hamid United States

J Dřímal Slovakia

Michelle Pacholec United States

Karl Romstedt United States

Lars Ynddal Denmark

John P. Mogensen

304 ×1.0

69 ×0.8

70 ×0.9

PHYSI

62 ×1.2

PHARM

39 ×0.8

BIOCH

Citations per year, relative to John P. Mogensen John P. Mogensen (= 1×) peers Lars Ynddal

Countries citing papers authored by John P. Mogensen

Since Specialization

Citations

This map shows the geographic impact of John P. Mogensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Mogensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Mogensen more than expected).

Fields of papers citing papers by John P. Mogensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Mogensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Mogensen. The network helps show where John P. Mogensen may publish in the future.

Co-authorship network of co-authors of John P. Mogensen

This figure shows the co-authorship network connecting the top 25 collaborators of John P. Mogensen. A scholar is included among the top collaborators of John P. Mogensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. Mogensen. John P. Mogensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Sauerberg, Per, et al.. (2007). Novel selective PPARδ agonists: Optimization of activity by modification of alkynylallylic moiety. Bioorganic & Medicinal Chemistry Letters. 17(15). 4144–4149. 10 indexed citations

Sauerberg, Per, John P. Mogensen, Lone Jeppesen, et al.. (2007). Design of potent PPARα agonists. Bioorganic & Medicinal Chemistry Letters. 17(11). 3198–3202. 13 indexed citations

Pettersson, Ingrid, et al.. (2007). Design of a partial PPARδ agonist. Bioorganic & Medicinal Chemistry Letters. 17(16). 4625–4629. 15 indexed citations

Sauerberg, Per, Grith Skytte Olsen, Lone Jeppesen, et al.. (2007). Identification and Synthesis of a Novel Selective Partial PPARδ Agonist with Full Efficacy on Lipid Metabolism In Vitro and In Vivo. Journal of Medicinal Chemistry. 50(7). 1495–1503. 18 indexed citations

Nehlin, Jan O., John P. Mogensen, Lone Jeppesen, et al.. (2006). Selective PPAR Agonists for the Treatment of Type 2 Diabetes. Annals of the New York Academy of Sciences. 1067(1). 448–453. 12 indexed citations

Sauerberg, Per, John P. Mogensen, Lone Jeppesen, et al.. (2005). Structure–activity relationships of dimeric PPAR agonists. Bioorganic & Medicinal Chemistry Letters. 15(5). 1497–1500. 11 indexed citations

Frederiksen, Klaus Stensgaard, Erik Max Wulff, Per Sauerberg, et al.. (2004). Prediction of PPAR-α ligand-mediated physiological changes using gene expression profiles. Journal of Lipid Research. 45(3). 592–601. 53 indexed citations

Tagmose, Tina M., John P. Mogensen, Flemming Nielsen, et al.. (2004). Arylcyanoguanidines as Activators of Kir6.2/SUR1K_ATP Channels and Inhibitors of Insulin Release. Journal of Medicinal Chemistry. 47(12). 3202–3211. 10 indexed citations

Tagmose, Tina M., Florencio Zaragoza, Harrie C. M. Boonen, et al.. (2003). Synthesis and biological activity of 3,3-Diamino-sulfonylacrylonitriles as novel inhibitors of glucose induced insulin secretion from beta cells. Bioorganic & Medicinal Chemistry. 11(6). 931–940. 7 indexed citations

10.

Mogensen, John P., Lone Jeppesen, Paul S. Bury, et al.. (2003). Design and synthesis of novel PPARα/γ/δ triple activators using a known PPARα/γ dual activator as structural template. Bioorganic & Medicinal Chemistry Letters. 13(2). 257–260. 23 indexed citations

11.

Sauerberg, Per, Paul S. Bury, John P. Mogensen, et al.. (2003). Large Dimeric Ligands with Favorable Pharmacokinetic Properties and Peroxisome Proliferator-Activated Receptor Agonist Activity in Vitro and in Vivo. Journal of Medicinal Chemistry. 46(23). 4883–4894. 28 indexed citations

12.

Nielsen, Flemming, Thora Bödvarsdóttir, Anne Worsaae, et al.. (2002). 6-Chloro-3-alkylamino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-Dioxide Derivatives Potently and Selectively Activate ATP Sensitive Potassium Channels of Pancreatic β-Cells. Journal of Medicinal Chemistry. 45(19). 4171–4187. 40 indexed citations

13.

Sauerberg, Per, Ingrid Pettersson, Lone Jeppesen, et al.. (2002). Novel Tricyclic-α-alkyloxyphenylpropionic Acids: Dual PPARα/γ Agonists with Hypolipidemic and Antidiabetic Activity. Journal of Medicinal Chemistry. 45(4). 789–804. 126 indexed citations

14.

Tagmose, Tina M., John P. Mogensen, Per Arkhammar, et al.. (2001). Phenylcyanoguanidines as inhibitors of glucose-induced insulin secretion from beta cells. Bioorganic & Medicinal Chemistry Letters. 11(13). 1749–1752. 7 indexed citations

15.

Mogensen, John P., et al.. (1998). The synthesis of new adenosine A3 selective ligands containing bioisosteric isoxazoles. Bioorganic & Medicinal Chemistry Letters. 8(13). 1767–1770. 21 indexed citations

16.

Hansen, John Bondo, Anders Fink‐Jensen, B Christensen, et al.. (1998). Mesolimbic selective antipsychotic arylcarbamates. European Journal of Medicinal Chemistry. 33(11). 839–858. 4 indexed citations

17.

Knutsen, Lars J. S., Malcolm J. Sheardown, Stanley M. Roberts, et al.. (1998). Adenosine A1 and A3 selectiveN-alkoxypurines as novel cytokine modulators and neuroprotectants. Drug Development Research. 45(3-4). 214–221. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact